Karaz Health

What Karaz Health does

Karaz Health, founded in 2020 and headquartered in Riyadh, Saudi Arabia, operates an AI-driven Electronic Health Record (EHR) platform focused on diabetes and broader metabolic health. The platform is built around two core products: a free consumer-facing mobile application that integrates with continuous glucose monitors (CGMs) and other biometric devices, and an enterprise EHR layer that aggregates patient data into a unified dashboard for clinicians. Underlying technology combines real-time CGM and device data ingestion from seven major hardware brands (Apple, Abbott, Medtronic, Dexcom, Roche, Google Health, Omron), AI-generated personalized insights and action plans, a gamified reward system that monetizes behavioral adherence, and supplementary modules including telemedicine, at-home lab tests, psychological support, behavioral health, prediabetes/weight management, and an in-app marketplace for health-related products.

Karaz serves four distinct participant groups within a single ecosystem: healthcare practitioners, health coverage providers (insurers and payers), wellness-driven individuals (patients with diabetes or prediabetes, and health-conscious consumers), and vendors or business partners. The company holds Saudi Food and Drug Authority (SFDA) approval, ISO 27001 (information security), and ISO 14971 (medical device risk management) certifications, and was named a Digital Health Award Winner in Fall 2022. A retrospective clinical study of 384 users in Saudi Arabia was published in Nature in November 2025, documenting statistically significant Time in Range improvements after three months of app usage.

Karaz operates a hybrid go-to-market: a product-led growth motion through a free mobile app distributed via app stores for individual consumers, paired with an enterprise sales motion targeting healthcare practitioners, insurers, government bodies, and vendors through a website demo request flow. Revenue streams include (or are expected to include) B2B platform and licensing fees from institutional clients, marketplace commissions from third-party sellers, and fees from at-home lab tests and diabetic supplies. Karaz is led by CEO Suliman Alblowi and COO Amir Raouf; the company operates with a headcount of 11-50 employees.

Name

Karaz Health

Legal name

Karaz App

Website

https://karaz.app

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Short description

Karaz Health operates an AI-driven EHR platform for diabetes and metabolic health, combining a free consumer mobile app with CGM integrations across seven device brands and a B2B sales motion to clinicians, payers, and government bodies in Saudi Arabia.

Ownership category

akta.pro rank

Product category

Digital Health / Diabetes Management Platform

NAICS

Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (51821), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518210)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators) (HLAHAHAJ)

akta.pro secondary industries

Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF), Multi-Condition RPM Platforms & Care Orchestration (device-agnostic, population management) (HLALAFAL), Medical-Grade Device Connectivity & Device Management (MDM) (HLACAFAG), Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA), Remote Patient Monitoring (RPM) Platforms & Device Hubs (Connectivity/Gateways) (HLAHACAH)

Keywords

• Diabetes management platform
• Continuous glucose monitoring
• Electronic health records
• Health data analytics
• Digital therapeutics

Headquarters

HQ city

Riyadh

HQ country

Saudi Arabia

HQ region

Middle East

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. App-based services (freemium model): Karaz operates primarily as a free app for individual users. Basic app usage (health monitoring, CGM integration, insights, rewards) is provided at no cost to users, with monetization likely driven through B2B institutional contracts rather than direct consumer subscriptions.
2. B2B enterprise licensing / platform fees: Karaz targets healthcare practitioners, health coverage providers, insurance companies, and government bodies as institutional customers who would pay for access to the platform's enterprise features, reporting, and patient management tools. Revenue is derived from platform/service fees to institutional clients.
3. Marketplace commissions: Karaz operates an online marketplace for health-related products. Karaz accepts binding sales requests on behalf of sellers and facilitates transactions, generating revenue through the marketplace platform.
4. At-home lab tests and supplies: At-home lab tests and diabetic supplies are offered as part of the service offering, likely generating revenue through product sales or commission on third-party supply fulfillment.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Karaz Health operates an AI-driven Electronic Health Records (EHR) platform focused on diabetes and metabolic health management. The platform integrates data from Continuous Glucose Monitoring (CGM) devices and other biometric tools (Apple Health, Abbott, Medtronic, Dexcom, Roche, Google Health, Omron) to deliver personalized, data-driven treatment plans, real-time insights, and gamified adherence tools for patients and clinicians.

Product overview

Karaz Health offers a unified, AI-driven EHR ecosystem centered on diabetes and metabolic health management. The core offering consists of the Karaz AI-Driven EHR Platform and Karaz Mobile Application, which together provide continuous glucose monitoring (CGM) integration, real-time patient insights, and a gamification-based rewards system. Additional modules include Data-Driven Diabetic Plans, At-Home Lab Tests, Diabetic Psychological Support, Diabetic Behavioral Health, Prediabetes & Weight Management, and Telemedicine — all accessible through the same platform. The Karaz Marketplace extends the ecosystem by enabling purchase of health-related products. The platform serves four participant groups: Healthcare Practitioners, Health Coverage Providers, Wellness-driven Individuals, and Vendors & Business Partners.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• TIR improved from 43.1% to 45.89% in users with suboptimal baseline glucose control (TIR <= 60%) after 3 months of app usage
• +3 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration7 records

AI capability5 records

Feature6 records

Partnerships

Seven partnerships are on record, tiered core.

• Apple HealthcoreTechnology or IntegrationApple Health integration allows Karaz users to connect Apple health data and devices to the Karaz platform, enabling a holistic view of patient health through Apple's ecosystem of health monitoring tools.
• AbbottcoreTechnology or IntegrationAbbott's CGM devices (FreeStyle Libre) integrate with Karaz, allowing real-time glucose data to flow into the Karaz EHR platform for monitoring, analysis, and AI-driven insights.
• MedtroniccoreTechnology or IntegrationMedtronic CGM and insulin pump integration with Karaz enables patients to share real-time glucose and insulin data with healthcare providers through the Karaz platform.
• DexcomcoreTechnology or IntegrationDexcom CGM device integration with Karaz allows seamless transfer of continuous glucose monitoring data into the Karaz app and EHR dashboard for real-time monitoring and clinical decision support.
• RochecoreTechnology or IntegrationRoche's diabetes management devices and health technology integrations connect with the Karaz platform, expanding the ecosystem of devices supported for comprehensive metabolic health monitoring.
• Google HealthcoreTechnology or IntegrationGoogle Health integration enables data connectivity and health ecosystem interoperability for Karaz users, leveraging Google's health data standards and platform capabilities.
• OmroncoreTechnology or IntegrationOmron's blood pressure monitors and other health devices integrate with Karaz, providing additional biometric data points for comprehensive patient health monitoring beyond glucose.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Glooko: Diabetes data management platform that aggregates data from dozens of CGM and insulin devices. Directly comparable to Karaz on device-agnostic integration, multi-stakeholder positioning (patients, providers, payers), and AI-driven insights.
• One Drop: AI-powered diabetes management app with CGM integration, coaching, and B2B contracts with employers and insurers. Closely matches Karaz's freemium-to-enterprise GTM and behavioral-coaching layer.
• Virta Health: Diabetes reversal platform using AI-driven nutrition and clinician coaching, sold to payers and employers on a value-based care model. Overlaps with Karaz on diabetes outcomes focus and payer contracting motion.
• DarioHealth: Digital therapeutics platform spanning diabetes, hypertension, and musculoskeletal conditions with B2B payer/employer contracts. Comparable to Karaz's multi-condition cardiometabolic roadmap and enterprise GTM.
• mySugr (Roche): Diabetes self-management app acquired by Roche. Direct competitor: integrates CGM devices, offers AI-driven coaching, and operates a freemium consumer model — closely matching Karaz's core offering while benefiting from Roche's device ecosystem and global scale.
• WellDoc (BlueStar): FDA-cleared digital therapeutic for diabetes (BlueStar) with AI-driven insulin dosing and CGM integration. Closely matches Karaz's positioning as a regulated, clinically validated diabetes digital therapeutic targeting payers and providers.

Broad incumbents

• Livongo (Teladoc Health): Chronic condition management platform (diabetes, hypertension, weight) now part of Teladoc. Comparable to Karaz on CGM integration, behavioral coaching, and payer contracts, but operates as part of a much broader telehealth incumbent.

Emerging players

• BeatO: India-based diabetes management app with CGM integration, coaching, and a marketplace for diabetes supplies. Comparable to Karaz on the emerging-market playbook (freemium + marketplace + behavioral economics) but operates in a different geography.

Regional players

• Alma Health: MENA-focused digital health platform offering chronic disease management including diabetes, with employer and insurer contracts across the GCC. The most direct regional peer to Karaz in terms of geography and payer GTM.
• Okadoc: MENA-based telehealth and provider booking platform serving the UAE and Saudi Arabia. Adjacent to Karaz in targeting the same regional healthcare digitization opportunity and same enterprise buyer base, though not a direct diabetes-app competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/Karaz_App
• Facebookfacebook.com/karaz.app.5
• LinkedInlinkedin.com/company/karaz-platform

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Karaz Health